Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali 3-jild 2-son (2022)
IMPACT OF METABOLIC AND CARDIOVASCULAR DISEASES ON THE COURSE OF COVID-19
Абдиева Гулнора Алиевна, Ташкенбаева Элеонора Негматовна
Annotatsiya
The article describes the impact of cardio-metabolic comorbidities on the severity and course of COVID-19. A total of 116 patients were included in the study. The highest risk of developing critical or fatal COVID-19 disease was in patients with underlying cardiovascular disease [OR: 3.44, 95% CI: 2.65–4.48], followed by chronic lung disease, hypertension, and diabetes mellitus. Of the total cases, 64% had one of four comorbidities (diabetes, hypertension, chronic lung disease, or cardiovascular disease), the most common being hypertension, with a combined prevalence of 27%. The presence of comorbidities such as cardiovascular disease, chronic lung disease, hypertension, and diabetes mellitus resulted in a higher risk of developing critical or fatal COVID-19 disease, with the highest risk occurring with underlying cardiovascular disease.
COVID-19, SARS-CoV-2, гипертония, сахарный диабет, сердечно-сосудистые заболевания.COVID-19, SARS-CoV-2, hypertension, diabetes mellitus, cardiovascular disease.COVID-19, SARS-CoV-2, gipertoniya, qandli diabet, yurak-qon tomir kasalliklari.
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.